Dolan J - Search Results

1

A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome.

Stiff P, Bayer R, Camarda M, Tan S, Dolan J, Potkul R, Loutfi S, Kinch L, Sosman J, Peace D, et al. Stiff P, et al. Among authors: dolan j. Gynecol Oncol. 1995 Jun;57(3):278-85. doi: 10.1006/gyno.1995.1143. Gynecol Oncol. 1995. PMID: 7774830 Clinical Trial.

2

Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.

Stiff PJ, McKenzie RS, Alberts DS, Sosman JA, Dolan JR, Rad N, McCloskey T. Stiff PJ, et al. Among authors: dolan jr. J Clin Oncol. 1994 Jan;12(1):176-83. doi: 10.1200/JCO.1994.12.1.176. J Clin Oncol. 1994. PMID: 8270975 Clinical Trial.

3

Retroperitoneal radical hysterectomy.

Delgado G, Potkul RK, Dolan JR. Delgado G, et al. Among authors: dolan jr. Gynecol Oncol. 1995 Feb;56(2):191-4. doi: 10.1006/gyno.1995.1030. Gynecol Oncol. 1995. PMID: 7896184

4

DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.

Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM. Dolan JR, et al. Gynecol Oncol. 1993 Feb;48(2):232-5. doi: 10.1006/gyno.1993.1039. Gynecol Oncol. 1993. PMID: 8428696

5

Lectin binding to common epithelial tumors of the ovaries.

Bychkov V, Dolan JR, Reddy VB. Bychkov V, et al. Among authors: dolan jr. Gynecol Obstet Invest. 1991;31(3):166-71. doi: 10.1159/000293143. Gynecol Obstet Invest. 1991. PMID: 2071056

6

MR imaging of uterine carcinoma: correlation with clinical and pathologic findings.

Posniak HV, Olson MC, Dudiak CM, Castelli MJ, Dolan J, Wisniewski RA, Isaacs JH, Sharma SK, Bychkov V. Posniak HV, et al. Among authors: dolan j. Radiographics. 1990 Jan;10(1):15-27. doi: 10.1148/radiographics.10.1.2296693. Radiographics. 1990. PMID: 2296693

7

Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway.

Kulshrestha A, Katara GK, Ibrahim SA, Riehl V, Sahoo M, Dolan J, Meinke KW, Pins MR, Beaman KD. Kulshrestha A, et al. Among authors: dolan j. J Oncol. 2019 Apr 1;2019:2343876. doi: 10.1155/2019/2343876. eCollection 2019. J Oncol. 2019. PMID: 31057611 Free PMC article.

8

Detection of localized breast cancer by prospective mammographic screening criteria.

Knaus JV, Dolan JR, Isaacs JH. Knaus JV, et al. Among authors: dolan jr. Am J Obstet Gynecol. 1988 Jan;158(1):147-9. doi: 10.1016/0002-9378(88)90799-5. Am J Obstet Gynecol. 1988. PMID: 2827485

9

In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.

Kulshrestha A, Katara GK, Ibrahim SA, Riehl VE, Schneiderman S, Bilal M, Young AN, Levine S, Fleetwood S, Dolan J, Gilman-Sachs A, Beaman KD. Kulshrestha A, et al. Among authors: dolan j. Mol Oncol. 2020 Oct;14(10):2436-2454. doi: 10.1002/1878-0261.12782. Epub 2020 Sep 10. Mol Oncol. 2020. PMID: 32797726 Free PMC article.

10

Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.

Kulshrestha A, Katara GK, Ginter J, Pamarthy S, Ibrahim SA, Jaiswal MK, Sandulescu C, Periakaruppan R, Dolan J, Gilman-Sachs A, Beaman KD. Kulshrestha A, et al. Among authors: dolan j. Mol Oncol. 2016 Jun;10(6):789-805. doi: 10.1016/j.molonc.2016.01.003. Epub 2016 Jan 29. Mol Oncol. 2016. PMID: 26899534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

565 results

Search Page

Filters